Subash Babu, MBBS, PhD, FASTMH, DIFASTMH, National Institute of Allergy and Infectious Diseases – International Center for Excellence in Research, India and National Institute of Allergy and Infectious Diseases – National Institutes of Health, United States
Image credit: © Dr_Microbe / stock.adobe.com
Subash Babu, MBBS, PhD, FASTMH, DIFASTMH, National Institute of Allergy and Infectious Diseases – International Center for Excellence in Research, India and National Institute of Allergy and Infectious Diseases – National Institutes of Health, United States
Dr Subash Babu is the scientific director of NIAID ICER, a partnership between NIAID and the Indian Ministry of Health and Family Welfare. He earned his medical degree from the University of Madras and his PhD in immunology from the University of Connecticut. His research focuses on the epidemiology and immunology of infectious diseases prevalent in India, including helminth infections, TB, HIV, and COVID-19.
Ongoing research in this field not only supports the fight against TB but also encourages collaborative efforts and interdisciplinary approaches. By fostering such collaborations, we can drive progress toward eradicating TB and ensuring health for all.
While challenges persist in advancing the field, innovations in biomarker discovery hold the potential to lead to more precise diagnostics and personalized treatment strategies. Additionally, improvements in animal models could enhance our understanding of the disease's pathogenesis and host response. Such breakthroughs would have far-reaching implications, not only for TB but for infectious disease research as a whole.
We invite researchers to contribute to this special Collection by submitting original research articles, reviews, and case studies. Topics of interest include but are not limited to:
• Biomarker identification and validation
• Novel animal models for TB research
• Treatment monitoring strategies
• Clinical applications of biomarkers
• Environmental factors influencing TB
• Immunological responses in TB models
• Drug discovery and development pathways
• Host-pathogen interactions and immune evasion mechanisms
• Multi-omics approaches for TB research
• TB latency, reactivation, and disease progression
• TB co-infections (HIV, diabetes, helminths, etc.)
• Advancements in TB vaccines and immunotherapy
• Point-of-care diagnostics and rapid testing technologies
Image credit: © Dr_Microbe / stock.adobe.com
There are currently no articles in this collection.
This Collection welcomes submission of original research articles, reviews, and case studies. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Biomarkers and Animal Models for Tuberculosis Research, Diagnosis and/or Treatment Monitoring" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
